CancerNetwork Members: Login | Register
 
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
PATIENTS
NURSES
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

Oncology NEWS International. Vol. 17 No. 12
PRACTICAL BILLING TIPS: 

Phone-time vs face-time: CMS covers limited non-drug services

BY RONALD PIANA | December 1, 2008
In today’s tight fiscal environment, every dollar-capture counts and every billing error adds to administrative costs.

Joseph S. Bailes, MD EditorThe ever-growing complexity of chemotherapy coding is so onerous that office managers sometimes lose track of their non-drug billing items. Here are four questions that oft en pop up about nondrug billing and coding.

Q: I can’t get a needy patient off the phone. Can I bill for phone time?

A: Medicare and Medicaid do not make separate payments for services rendered through telephone calls except under Care Plan Oversight Services.

“Physician work resulting from telephone calls is considered to be an integral part of the pre-work and post-work of other physician services, and the fee schedule amount for the latter services already includes payment for the telephone calls,” according to ASCO Practical Tips for the Oncology Practice. As far as E&M services, Medicare and Medicaid pay only for face-to-face contact.

Q: I’m part of a six-doctor community practice. What is Medicare’s criterion for electronic billing for a small practice?

A: All Medicare claims must be filed electronically, although there are exceptions. Small practices are defi ned as entities with fewer than 10 full-time equivalent employees and receive exempt status. But this electronic filing requirement applies only to the initial claim. Subsequent changes, adjustments, or appeals do not have to be filed electronically.

Q: How do I know if lab tests are being properly documented at my practice?

A: First off , lab services are billed with Current Procedural Terminology (CPT) codes: 80048-89240. Every test billed to Medicare must be medically necessary for the patient involved even if the test was part of an automated panel.

To avoid Medicare challenges, the patient’s medical records should individually list all of the medically necessary blood chemistry tests and/or any of the CPT panels (80048-80076).

If you don’t list individual tests or panels, it doesn’t mean you won’t be reimbursed, but it may prompt a Medicare query, especially when numerous tests are ordered.

Q: What about reimbursement for the cost of disposable supplies? For instance, is saline considered a drug or supply?

A: In general, Medicare does not make a separate payment for disposable supplies used in a physician’s office.

Medicare contends that it pays at a level for each service that covers the component costs of supplies.

Saline is eligible for Medicare payment when infused into a patient and should be billed using the appropriate J-code. However, Medicare coverage varies on separate payment for saline that is not infused, but is instead used as a port flush or to mix drugs. So it’s important to check with your local carrier to verify what is considered a supply.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

  • Bladder Cancer
  • Bone Metastases
  • Breast Cancer
  • CML
  • Colorectal Cancer
  • End-of-Life
  • GIST
  • Genetics Genomics
  • Gynecologic Cancers
  • Head & Neck Cancer
  • Integrative Oncology
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Nausea & Vomiting
  • Palliative Care
  • Pancreatic Cancer
  • Practice Management
  • Practice & Policy
  • Prostate Cancer
  • RCC
  • Skin Cancer
  • Triple-Negative Breast
  • Testicular Cancer


More Topics 

 
PUBLICATIONS
ONCOLOGY Journal ONCOLOGY Nurse Edition Journal Cancer Management: A Multidisciplinary Approach

ONCOLOGY:
Perspectives on Best Practices

ONCOLOGY:
Nurse Edition

CANCER
MANAGEMENT
:
A Multidisciplinary
Approach


 
IMAGE IQ

Other than surgical interventions, which medication might be most appropriate for this patient?

A 68-year-old woman presented with a mass on the scalp. An incisional biopsy of the scalp mass and an excisional biopsy of the lymph node both revealed basal cell carcinoma.

 

More Image IQs:

 

 
FROM PHYSICIANS PRACTICE
'What They Should Really Teach in Medical School'
Julie Schopps, MD , February 6, 2012
The North Carolina-based pediatrician weighs in on why she thinks the real learning doesn't take place until students are out of the classroom.
Improve EHR Systems by Rethinking Medical Billing
Daniel Essin, MA, MD, February 6, 2012
Separating billing-related data from other clinical documentation and transmitting it to a billing system is not difficult …no matter how the charting is done.
Keeping Your Medical Practice’s Accounts Receivable on Track
P.J. Cloud-Moulds, February 4, 2012
Here are the minimum reports you should be running to keep an eye on your practices A/R.
Healthcare Providers Play Crucial Role in Helping Victims of Abuse
Stephen Hanson, PA-C , February 3, 2012
I would urge each and every one of you to be familiar with the warning signs of abuse, and the resources available to you all as healthcare providers.
Protecting Your Medical Practice's Data
Marisa Torrieri, February 3, 2012
Here's the scoop on how to implement a good data-backup plan at your office.
 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Management of Brain Metastases: Neurosurgical Considerations
  • Head and Neck Tumors
  • Optimizing Outcomes of Advanced Prostate Cancer: Drug Sequencing and Novel Therapeutic Approaches
  • A 28-Year-Old Woman Presents With a Long-Standing History of Intermittently Painful “Bumps” on Both Her Shoulders and Upper Back
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • Ending the Shortage of Generic Oncology Drugs
  • Processed and Red Meat Consumption Linked to Slight Increase in Risk of Pancreatic Cancer
  • Younger Breast Cancer Patients Have More Adverse Quality of Life Issues
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • New Way to Predict Prostate Cancer Severity—Size of Prostate
  • AL Amyloidosis: Who, What, When, Why, and Where
  • The Maze of PARP Inhibitors in Ovarian Cancer
  • The Circuitous Path of PARP Inhibitor Development in Epithelial Ovarian Cancer
  • Podcast: Dr. David Ahlquist on Advances in Colorectal Cancer Screening
  • Lung Cancer Screening: A New Era
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • When to Treat Myelodysplastic Syndromes
  • ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
  • PSA Screening for Prostate Cancer Put Into Question By the U.S. Preventive Services Task Force
  • PSA Screening for Prostate Cancer Put Into Question By the U.S. Preventive Services Task Force
  • When to Treat Myelodysplastic Syndromes
  • ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
  • Are We Ready for Neoadjuvant Therapy in Potentially Resectable Pancreatic Cancer?
  • Evolving Therapeutic Paradigms for Advanced Prostate Cancer
Click here to subscribe to our newsletter
 
JOB LISTINGS

Post a job

Powered by SearchMedica Jobs



CancerNetwork on Facebook

 

CancerNetwork | CME LLC | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2012 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy